Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity

Authors: Titta M Salopuro, Timo Saaristo, Heikki Oksa, Hannu Puolijoki, Mauno Vanhala, Tapani Ebeling, Leo Niskanen, Jaakko Tuomilehto, Matti Uusitupa, Markku Peltonen

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

The implementation project of the national diabetes prevention programme in Finland, FIN-D2D, was carried out in primary health care in the area of five hospital districts during 2003-2007.

Methods

The population strategy of FIN-D2D was primarily aimed at increasing the awareness of type 2 diabetes and preventing obesity. To investigate the effects of this strategy, we studied the changes in the prevalence of obesity, overweight, and central obesity among a random independent sample of individuals aged 45-74 years in the FIN-D2D area; and assessed whether they differed from a sample of individuals in the control area, which consisted of four geographical areas not participating in FIN-D2D (FINRISK study). Data was obtained for 5850/ 6406 (in the beginning/ in the end) individuals. The duration of the observation period varied from three to five years.

Results

The mean body weight decreased from 78.7 to 78.1 kg (p = 0.041) in the FIN-D2D area, and from 78.7 to 78.0 kg (p = NS) in the control area. The prevalence of obesity (BMI ≥30 kg/m2) decreased in the FIN-D2D area (26.5% vs. 24.4%, p = 0.015), and in the control area (28.4% vs. 25.2%, p = 0.005). The prevalence of morbid obesity (BMI ≥40 kg/m2) remained unchanged in the FIN-D2D area, but increased in the control area (1.2% vs. 2.3%, p = 0.007). The mean waist circumference remained unchanged in the FIN-D2D area, but increased in the control area (92.8 vs. 94.0 cm, p = 0.005).

Conclusions

The prevalence of obesity may be decreasing among 45-74 year old Finns. We still need a longer time perspective and future studies to see whether this favourable trend can be sustained in Finland. The actions of this implementation project can at least partly explain the differences in the mean waist circumference and the prevalence of morbid obesity between the intervention and control areas.
Appendix
Available only for authorised users
Literature
1.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006, 295 (13): 1549-1555. 10.1001/jama.295.13.1549.CrossRefPubMed
2.
Kautiainen S, Rimpelä A, Vikat A, Virtanen SM: Secular trends in overweight and obesity among Finnish adolescents in 1977-1999. Int J Obes Relat Metab Disord. 2002, 26 (4): 544-552. 10.1038/sj.ijo.0801928.CrossRefPubMed
3.
Flegal KM, Carroll MD, Ogden CL, Curtin LR: Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010, 303 (3): 235-241. 10.1001/jama.2009.2014.CrossRefPubMed
4.
Vartiainen E, Peltonen M, Laatikainen T, Sundvall J, Salomaa V, Jousilahti P, Puska P: FINRISKI-tutkimus: Sekä miesten että naisten sydän- ja verisuonisairauksien kokonaisriski pieneni viime vuosina. Suom Lääkäril. 2008, 63 (15): 1375-1381.
5.
Trayhurn P, Bing C, Wood IS: Adipose tissue and adipokines - energy regulation from the human perspective. J Nutr. 2006, 136 (7 Suppl): 1935S-1939S.PubMed
6.
Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L: The impact of obesity on the musculoskeletal system. Int J Obes (Lond). 2008, 32 (2): 211-222. 10.1038/sj.ijo.0803715.CrossRef
7.
Popkin BM, Kim S, Rusev ER, Du S, Zizza C: Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev. 2006, 7 (3): 271-293. 10.1111/j.1467-789X.2006.00230.x.CrossRefPubMed
8.
Adler A: Obesity and target organ damage: diabetes. Int J Obes Relat Metab Disord. 2002, 26 (Suppl 4): S11-14.CrossRefPubMed
9.
Cummings DE, Schwartz MW: Genetics and pathophysiology of human obesity. Annu Rev Med. 2003, 54: 453-471. 10.1146/annurev.med.54.101601.152403.CrossRefPubMed
10.
DECODE Study Group: Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003, 26 (1): 61-69. 10.2337/diacare.26.1.61.CrossRef
11.
Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group: Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999, 354 (9179): 617-621.CrossRef
12.
Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
13.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344 (18): 1343-1350. 10.1056/NEJM200105033441801.CrossRefPubMed
14.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346 (6): 393-403.CrossRefPubMed
15.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997, 20 (4): 537-544. 10.2337/diacare.20.4.537.CrossRefPubMed
16.
Kosaka K, Noda M, Kuzuya T: Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005, 67 (2): 152-162. 10.1016/j.diabres.2004.06.010.CrossRefPubMed
17.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP): The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006, 49 (2): 289-297. 10.1007/s00125-005-0097-z.CrossRefPubMed
18.
Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH: The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008, 371 (9626): 1783-1789. 10.1016/S0140-6736(08)60766-7.CrossRefPubMed
19.
Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study Group: Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006, 368 (9548): 1673-1679. 10.1016/S0140-6736(06)69701-8.CrossRefPubMed
20.
Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009, 374 (9702): 1677-1686. 10.1016/S0140-6736(09)61457-4.CrossRefPubMedCentral
21.
Cardona-Morrell M, Rychetnik L, Morrell SL, Espinel PT, Bauman A: Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health. 2010, 10: 653-10.1186/1471-2458-10-653.CrossRefPubMedPubMedCentral
22.
23.
Saaristo T, Peltonen M, Keinänen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, Oksa H, Korpi-Hyövälti E, Tuomilehto J, FIN-D2D Study Group: National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health. 2007, 66 (2): 101-112.CrossRefPubMed
24.
Saaristo TE, Barengo NC, Korpi-Hyövälti E, Oksa H, Puolijoki H, Saltevo JT, Vanhala M, Sundvall J, Saarikoski L, Peltonen M, Tuomilehto J: High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health. 2008, 8: 423-10.1186/1471-2458-8-423.CrossRefPubMedPubMedCentral
25.
26.
Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Jokelainen J, Peltonen M, Oksa H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S: Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010, 33 (10): 2146-2151. 10.2337/dc10-0410.CrossRefPubMedPubMedCentral
27.
Puska P, Koskela K, Pakarinen H, Puumalainen P, Soininen V, Tuomilehto J: The North Karelia Project: a programme for community control of cardiovascular diseases. Scand J Soc Med. 1976, 4 (2): 57-60.PubMed
28.
Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P: Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol. 2000, 29 (1): 49-56. 10.1093/ije/29.1.49.CrossRefPubMed
29.
The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol. 1988, 41 (2): 105-114. 10.1016/0895-4356(88)90084-4.
30.
Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome - a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
31.
Han TS, van Leer EM, Seidell JC, Lean ME: Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995, 311 (7017): 1401-1405.CrossRefPubMedPubMedCentral
32.
Lahti-Koski M, Harald K, Männistö S, Laatikainen T, Jousilahti P: Fifteen-year changes in body mass index and waist circumference in Finnish adults. Eur J Cardiovasc Prev Rehabil. 2007, 14 (3): 398-404. 10.1097/HJR.0b013e32800fef1f.CrossRefPubMed
33.
Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN: Obesity prevalence from a European perspective: a systematic review. BMC Public Health. 2008, 8: 200-10.1186/1471-2458-8-200.CrossRefPubMedPubMedCentral
34.
Aranceta J, Perez-Rodrigo C, Serra-Majem L, Bellido D, de la Torre ML, Formiguera X, Moreno B: Prevention of overweight and obesity: a Spanish approach. Public Health Nutr. 2007, 10 (10A): 1187-1193.CrossRefPubMed
35.
Katzmarzyk PT: The Canadian obesity epidemic: an historical perspective. Obes Res. 2002, 10 (7): 666-674. 10.1038/oby.2002.90.CrossRefPubMed
36.
Bendixen H, Holst C, Sorensen TI, Raben A, Bartels EM, Astrup A: Major increase in prevalence of overweight and obesity between 1987 and 2001 among Danish adults. Obes Res. 2004, 12 (9): 1464-1472. 10.1038/oby.2004.183.CrossRefPubMed
37.
Marques-Vidal P, Dias CM: Trends in overweight and obesity in Portugal: the National Health Surveys 1995-6 and 1998-9. Obes Res. 2005, 13 (7): 1141-1145. 10.1038/oby.2005.135.CrossRefPubMed
38.
Dal Grande E, Gill T, Taylor AW, Chittleborough C, Carter P: Obesity in South Australian adults - prevalence, projections and generational assessment over 13 years. Aust N Z J Public Health. 2005, 29 (4): 343-348. 10.1111/j.1467-842X.2005.tb00205.x.CrossRefPubMed
39.
Sundquist J, Johansson SE, Sundquist K: Leveling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health. 2010, 10 (1): 119-10.1186/1471-2458-10-119.CrossRefPubMedPubMedCentral
40.
Sundquist K, Qvist J, Johansson SE, Sundquist J: Increasing trends of obesity in Sweden between 1996/97 and 2000/01. Int J Obes Relat Metab Disord. 2004, 28 (2): 254-261.PubMed
41.
Borodulin K, Laatikainen T, Juolevi A, Jousilahti P: Thirty-year trends of physical activity in relation to age, calendar time and birth cohort in Finnish adults. Eur J Public Health. 2008, 18 (3): 339-344. 10.1093/eurpub/ckm092.CrossRefPubMed
42.
43.
Assaf AR, Parker D, Lapane KL, Coccio E, Evangelou E, Carleton RA: Does the Y chromosome make a difference? Gender differences in attempts to change cardiovascular disease risk factors. J Womens Health (Larchmt). 2003, 12 (4): 321-330. 10.1089/154099903765448835.CrossRef
44.
Rejeski WJ, Brawley LR, Ambrosius WT, Brubaker PH, Focht BC, Foy CG, Fox LD: Older adults with chronic disease: benefits of group-mediated counseling in the promotion of physically active lifestyles. Health Psychol. 2003, 22 (4): 414-423.CrossRefPubMed
45.
Hankonen N, Absetz P, Ghisletta P, Renner B, Uutela A: Gender differences in social cognitive determinants of exercise adoption. Psychology & Health. 2009, 1-15.
46.
Wong M, Gucciardi E, Li L, Grace SL: Gender and nutrition management in type 2 diabetes. Can J Diet Pract Res. 2005, 66 (4): 215-220. 10.3148/66.4.2005.215.CrossRefPubMed
47.
Lahti-Koski M, Seppänen-Nuijten E, Männistö S, Härkänen T, Rissanen H, Knekt P, Rissanen A, Heliövaara M: Twenty-year changes in the prevalence of obesity among Finnish adults. Obes Rev. 2009, 11: 171-176.CrossRefPubMed
48.
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB: Years of life lost due to obesity. JAMA. 2003, 289 (2): 187-193. 10.1001/jama.289.2.187.CrossRefPubMed
Metadata
Title
Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity
Authors
Titta M Salopuro
Timo Saaristo
Heikki Oksa
Hannu Puolijoki
Mauno Vanhala
Tapani Ebeling
Leo Niskanen
Jaakko Tuomilehto
Matti Uusitupa
Markku Peltonen
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-350

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue

Research article

Is 'Opt-Out HIV Testing' a real option among pregnant women in rural districts in Kenya?

Research article

Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country

Research article

Policy environment and male circumcision for HIV prevention: Findings from a situation analysis study in Tanzania

Research article

Using clinical trial data and linked administrative health data to reduce the risk of adverse events associated with the uptake of newly released drugs by older Australians: a model process

Study protocol

Rationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care setting

Study protocol

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking